TipRanks
Advertisement
Advertisement

GH Stock Latest News

Guardant to present 25 abstracts on liquid biopsy research portfolio at ESMO
The FlyGuardant to present 25 abstracts on liquid biopsy research portfolio at ESMO
2h ago
GH
Aquestive, Guardant, AFLAC, Baozun, Arqit: Insider Shake-Up
PremiumWeekend Updates
Aquestive, Guardant, AFLAC, Baozun, Arqit: Insider Shake-Up
3d ago
GH
AFL
TwinStrand Biosciences says US PTABL rejects Guardant challenge to patent
PremiumThe Fly
TwinStrand Biosciences says US PTABL rejects Guardant challenge to patent
5d ago
GH
Guardant presents data from role of blood-based testing in CRC screening
PremiumThe Fly
Guardant presents data from role of blood-based testing in CRC screening
5d ago
GH
Cathie Wood Just Sold $3.36M in META Stock. Here’s What She Bought Instead
PremiumMarket News
Cathie Wood Just Sold $3.36M in META Stock. Here’s What She Bought Instead
7d ago
GH
ALMR
Guardant Health price target raised to $200 from $185 at Morgan Stanley
PremiumThe FlyGuardant Health price target raised to $200 from $185 at Morgan Stanley
8d ago
GH
Guardant Health price target raised to $200 from $195 at BofA
Premium
The Fly
Guardant Health price target raised to $200 from $195 at BofA
11d ago
GH
Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion
Premium
The Fly
Guardant announces Europe approval of Guardnat360 CDx as Etcamaha companion
12d ago
GH
AZN
Guardant Health price target raised to $220 from $200 at Barclays
PremiumThe Fly
Guardant Health price target raised to $220 from $200 at Barclays
13d ago
GH
Guardant Health reports COSMOS study published in Cancer Research Communications
PremiumThe Fly
Guardant Health reports COSMOS study published in Cancer Research Communications
15d ago
GH
Guardant Health price target raised to $200 from $190 at Guggenheim
PremiumThe Fly
Guardant Health price target raised to $200 from $190 at Guggenheim
19d ago
GH
Grail panel votes ‘closer than we expected,’ says BTIG
PremiumThe Fly
Grail panel votes ‘closer than we expected,’ says BTIG
26d ago
GH
ABT
Craig-Hallum sees potential for confusion after CMS fee schedule
PremiumThe FlyCraig-Hallum sees potential for confusion after CMS fee schedule
28d ago
GH
NEO
Guardant, Geo, Tower, TG, GigaCloud Insider Shake-Up
Premium
Weekend Updates
Guardant, Geo, Tower, TG, GigaCloud Insider Shake-Up
1M ago
GH
GCT
Guardant Health assumed with a Buy at UBS
Premium
The Fly
Guardant Health assumed with a Buy at UBS
1M ago
GH
Guardant Health initiated with a Buy at Rothschild & Co Redburn
PremiumThe Fly
Guardant Health initiated with a Buy at Rothschild & Co Redburn
1M ago
GH
Guardant Health: FDA Companion Dx Approval for Camizestrant Validates Longitudinal Liquid Biopsy and Supports Buy Rating
PremiumRatings
Guardant Health: FDA Companion Dx Approval for Camizestrant Validates Longitudinal Liquid Biopsy and Supports Buy Rating
1M ago
GH
Guardant announces FDA approval of Guardant360 CDx as companion diagnostic
PremiumThe Fly
Guardant announces FDA approval of Guardant360 CDx as companion diagnostic
2M ago
GH
AZN
Guardant Health management to meet with Piper Sandler
PremiumThe Fly
Guardant Health management to meet with Piper Sandler
2M ago
GH
Elevance update guidelines cover Freenome CRC test, says Guggenheim
PremiumThe FlyElevance update guidelines cover Freenome CRC test, says Guggenheim
2M ago
GH
ELV
Guardant Health’s Shield Blood test covered by Carelon Health Services
Premium
The Fly
Guardant Health’s Shield Blood test covered by Carelon Health Services
2M ago
GH
Guardant Health: Patent Ruling Seen as Manageable Overhang, Analyst Maintains Buy Rating on Favorable Risk–Reward
Premium
Ratings
Guardant Health: Patent Ruling Seen as Manageable Overhang, Analyst Maintains Buy Rating on Favorable Risk–Reward
2M ago
GH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >